PMV Pharmaceuticals Inc
Follow $PMVP
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PMVP by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PMVP moving today?
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PMVP overview
Related filings and maps
Congress activity in PMVP
No receipt-qualified Congressional disclosure is present for PMVP in the cached public ledger.
PMVP contract awards, year to date.
Public federal awards linked to this ticker.
PMVP lobbying filings, year to date.
Registered lobbying filings matched to PMV Pharmaceuticals Inc.